Nevia-001
Pre-clinical- Indications
- Ovarian cancer
Company intelligence / Profile preview
Nevia
Unknown, Unknown, Israelnevia.bio ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Nevia Bio focuses on transforming women's health through non-invasive early disease detection using biomarkers from vaginal secretions analyzed with machine learning. Their pipeline includes programs targeting ovarian cancer and endometriosis at clinical proof-of-concept stage. The company has received innovation awards and collaborates with leading clinicians in gynecologic oncology.
Nevia Biotech S.r.l./SA develops innovative pharmaceutical products primarily for respiratory diseases (notably non-allergic cell-mediated rhinitis), rheumatology disorders like fibromyalgia and pre-eclampsia, as well as pediatric neuropsychiatry conditions such as ADHD. Their CiliaCell product line addresses chronic rhinosinusitis and otitis media effusive.
- Therapeutic areas
- ImmunologyWomen's Health
- Modalities
- Biomarker discovery via vaginal secretions, machine learning-based diagnostics for early disease detection in women’s healthSmall molecules and pharmaceutical products for respiratory, rheumatology, neuropsychiatry indications
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships publicly listed; advisory board includes leaders from GOG Foundation/Vaniam Group/Mount Sinai Medical Center/Rambam Health Care Campus indicating strong academic/clinical ties.
Beyond the preview
Go deeper on Nevia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nevia.